10xgenomics

About 10xgenomics

10xgenomics is a leading biotechnology company specializing in the development of advanced tools for genomic analysis. Headquartered in Pleasanton, California, the company was founded in 2012 with a mission to accelerate biological discovery by enabling researchers to explore the complexity of the genome at unprecedented resolution. Operating at the intersection of biology and technology, 10xgenomics has established itself as a key player in the life sciences industry, providing innovative solutions that bridge the gap between raw data and meaningful biological insights. The company’s flagship products include the Chromium platform, which allows researchers to generate high-resolution data from single cells, tissues, and other biological samples. Key features of these solutions include multiplexing capabilities, scalability, and compatibility with various sequencing technologies, making them suitable for applications in cancer research, immunology, neuroscience, and developmental biology. 10xgenomics primarily targets academic institutions, pharmaceutical companies, and biotechnology firms seeking to uncover the molecular underpinnings of disease and normal biological processes. 10xgenomics has achieved significant recognition for its contributions to single-cell genomics, with its technologies being used in thousands of publications worldwide. The company holds a strong market position, driven by its reputation for innovation, robust product performance, and a commitment to advancing scientific understanding. By empowering researchers with cutting-edge tools, 10xgenomics continues to play a pivotal role in transforming genomic research and driving breakthroughs in medicine and biology.